Loading [Contrib]/a11y/accessibility-menu.js
Review

Modeling rare pediatric neurogenetic disorders with IPSCs

  • Intensive research has been performed to identify the pathological mechanisms of many pediatric neurogenetic disorders and to identify potential therapeutic targets. Although research into many pediatric neurological disorders has provided tremendous insight into the mechanisms of disease, effective treatments remain elusive. A significant impediment to progress has been a lack of thorough disease models. Transgenic/knockout animal models have been very valuable in determining the mechanisms of many neurogenetic disorders; however, these models cannot always mimic human-specific pathology and can be inadequate in representing human pathogenesis. This can be especially true for diseases of the nervous system. Alternatively, human patient-derived nervous tissue can be dangerous to acquire and difficult to propagate. The development of patient-derived induced pluripotent stem cells (IPSCs) has given researchers a fresh means of modeling these disorders with renewable human cells that can be used to generate neurons and glia. IPSCs are somatic cells that are reprogrammed back to a pluripotent stage, which can provide an unlimited source of human cells possessing patient-specific genetic mutations. Their potential to be differentiated into any cell type enables them to be a flexible platform to investigate neurogenetic disease. Of course, efficient methods for differentiating IPSCs into homogeneous populations of somatic cells must be established to provide the “disease-in-a-dish” systems. We will discuss the current methods for generating IPSC-derived neural cells to model pediatric neurogenetic disorders, as well as provide examples of the disorders that have been studied that include several neurodevelopmental and neurodegenerative disorders (Rett syndrome, spinal muscular atrophy, hereditary spastic paraplegias, and leukodystrophies). In addition, we provide examples on how patient-specific neural cells can be used in therapeutic development with high-throughput drug screening platforms or with correction via genome editing.

    Citation: Jaemin Kim, David Nonis, Maria Gabriela Otero, Tyler Mark Pierson. Modeling rare pediatric neurogenetic disorders with IPSCs[J]. AIMS Cell and Tissue Engineering, 2019, 3(1): 1-25. doi: 10.3934/celltissue.2019.1.1

    Related Papers:

    [1] Marie Vandekerckhove, Yu-lin Wang . Emotion, emotion regulation and sleep: An intimate relationship. AIMS Neuroscience, 2018, 5(1): 1-17. doi: 10.3934/Neuroscience.2018.1.1
    [2] Amanda G Bertollo, Roberta E Grolli, Marcos E Plissari, Vanessa A Gasparin, João Quevedo, Gislaine Z Réus, Margarete D Bagatini, Zuleide M Ignácio . Stress and serum cortisol levels in major depressive disorder: a cross-sectional study. AIMS Neuroscience, 2020, 7(4): 459-469. doi: 10.3934/Neuroscience.2020028
    [3] Nouhaila Chaoui, Hammou Anarghou, Meriem Laaroussi, Oumaima Essaidi, Mohamed Najimi, Fatiha Chigr . Long lasting effect of acute restraint stress on behavior and brain anti-oxidative status. AIMS Neuroscience, 2022, 9(1): 57-75. doi: 10.3934/Neuroscience.2022005
    [4] Yinghua Zhang, Xinyue Wei, Wenhao Zhang, Feng Jin, Wenbo Cao, Mingjin Yue, Saijun Mo . The BDNF Val66Met polymorphism serves as a potential marker of body weight in patients with psychiatric disorders. AIMS Neuroscience, 2024, 11(2): 188-202. doi: 10.3934/Neuroscience.2024012
    [5] Brian P. Leung, Kevin R. Doty, Terrence Town . Cerebral Innate Immunity in Drosophila Melanogaster. AIMS Neuroscience, 2015, 2(1): 35-51. doi: 10.3934/Neuroscience.2015.1.35
    [6] Ahlem Matallah, Rabie Guezi, Abdelmadjid Bairi . Repeated restraint stress induced neurobehavioral and sexual hormone disorders in male rats. AIMS Neuroscience, 2022, 9(2): 264-276. doi: 10.3934/Neuroscience.2022014
    [7] Daniel A. Barone, Ana C. Krieger . The Function of Sleep. AIMS Neuroscience, 2015, 2(2): 71-90. doi: 10.3934/Neuroscience.2015.2.71
    [8] Francesca Latino, Francesco Tafuri . The role of physical activity in the physiological activation of the scholastic pre-requirements. AIMS Neuroscience, 2024, 11(3): 244-259. doi: 10.3934/Neuroscience.2024016
    [9] Pranav Chintamani Joshi, Sugato Benerjee . Effects of glucocorticoids in depression: Role of astrocytes. AIMS Neuroscience, 2018, 5(3): 200-210. doi: 10.3934/Neuroscience.2018.3.200
    [10] Hannah P Priyanka, Rahul S Nair . Neuroimmunomodulation by estrogen in health and disease. AIMS Neuroscience, 2020, 7(4): 401-417. doi: 10.3934/Neuroscience.2020025
  • Intensive research has been performed to identify the pathological mechanisms of many pediatric neurogenetic disorders and to identify potential therapeutic targets. Although research into many pediatric neurological disorders has provided tremendous insight into the mechanisms of disease, effective treatments remain elusive. A significant impediment to progress has been a lack of thorough disease models. Transgenic/knockout animal models have been very valuable in determining the mechanisms of many neurogenetic disorders; however, these models cannot always mimic human-specific pathology and can be inadequate in representing human pathogenesis. This can be especially true for diseases of the nervous system. Alternatively, human patient-derived nervous tissue can be dangerous to acquire and difficult to propagate. The development of patient-derived induced pluripotent stem cells (IPSCs) has given researchers a fresh means of modeling these disorders with renewable human cells that can be used to generate neurons and glia. IPSCs are somatic cells that are reprogrammed back to a pluripotent stage, which can provide an unlimited source of human cells possessing patient-specific genetic mutations. Their potential to be differentiated into any cell type enables them to be a flexible platform to investigate neurogenetic disease. Of course, efficient methods for differentiating IPSCs into homogeneous populations of somatic cells must be established to provide the “disease-in-a-dish” systems. We will discuss the current methods for generating IPSC-derived neural cells to model pediatric neurogenetic disorders, as well as provide examples of the disorders that have been studied that include several neurodevelopmental and neurodegenerative disorders (Rett syndrome, spinal muscular atrophy, hereditary spastic paraplegias, and leukodystrophies). In addition, we provide examples on how patient-specific neural cells can be used in therapeutic development with high-throughput drug screening platforms or with correction via genome editing.


    Stress has become a prevalent concern in modern society, significantly affecting individuals' health and well-being. Its impact can manifest both directly, through physiological effects, and indirectly, through unhealthy behaviors such as excessive alcohol consumption, malnutrition, or poor sleep habits [1]. Therefore, motivating individuals to adapt their behaviors and lifestyles is crucial, while implementing effective strategies to develop stress-prevention mechanisms. This proactive approach becomes critical in preventing elevated stress levels from escalating into more severe health conditions.

    Accordingly, the damaging effects of stress extend beyond individual experiences, influencing broader societal dynamics. Recognizing stress' critical role in health outcomes, there is a growing need for innovative approaches to predict and manage stress levels. With the widespread adoption of wearable devices and interconnected devices capable of acquiring high-quality physiological data, there is a growing interest in leveraging these technologies to predict stress levels in real time. Recent literature [2] affirms the feasibility of objectively detecting stress through the analysis of biological data.

    This scientific review aims to outline the current landscape of stress assessment, providing insights into the advancements, challenges, and future directions within this rapidly evolving domain. Through the synthesis of existing research, the main objective is to contribute to a nuanced understanding of the potential of wearable technology in objectively assessing and predicting stress levels in real time. With rising concerns regarding stress, this review explores the potential impact of wearable devices on individual and public health outcomes [1][3]. It is imperative to underscore the significance of cardiometabolic diseases as a paramount public health concern due to their escalating prevalence worldwide. These innovative technologies facilitate assessing diverse health-related outcomes spanning molecular, clinical, and lifestyle domains. Currently, wearable devices equipped for continuous and longitudinal health monitoring outside traditional clinical settings offer valuable insights into varied populations' health and metabolic status, ranging from healthy individuals to those at different disease stages. We present an overview of the most relevant wearable and digital devices for evaluating indicators of cardiometabolic diseases. Additionally, we discuss how data acquired from such devices can advance our understanding of metabolic disorders, improve diagnostic accuracy, identify early-disease markers, and inform personalized treatment and prevention strategies [4].

    Furthermore, the objective is to provide a comprehensive overview of the current knowledge landscape, evaluate the strengths and limitations of previous models and methodologies, and identify research gaps that have yet to be addressed. More specifically, the primary focus areas to be covered include:

    i) Physiological indicators of stress: Reference to the physiological changes associated with stress, explicitly emphasizing metrics that wearable devices can record. Wearable sensors can continuously monitor physiological parameters like heart rate (HR) and breathing patterns. This real-time data can offer valuable insights into an individual's mental health. Specifically, variations in HR may serve as an indicator of stress or anxiety [5],[6]. This review will emphasize the current comprehension of the connections between these indicators and stress levels, evaluating the uniformity of these associations across various populations.

    ii) Wearable devices in stress monitoring: Reference the current utilization of wearable devices for collecting physiological data in stress prediction. Wearable sensors provide individuals with real-time feedback on indicators or biomarkers of their health, allowing them to recognize patterns that may indicate the need for behavioral interventions [7]. For instance, a wearable sensor can promptly notify an individual of an elevated HR, potentially indicating the presence of stress or anxiety. The review will assess the effectiveness of these devices in real-time monitoring of physiological indicators, evaluating their reliability in measuring stress-related changes. Nevertheless, it is crucial to acknowledge the various challenges of utilizing wearable sensors as stress detectors. These challenges encompass concerns regarding the accuracy and reliability of the collected data and issues surrounding the privacy and security of the information. It is, therefore, essential to consider the practical implications of integrating wearable devices into stress management interventions [8].

    iii) Research on stress prediction models: Reference to established models that utilize physiological data, such as heart rate variability (HRV) and sleep and breathing patterns (or even cortisol levels), for predicting stress levels. Continuous advancements in biotechnology are crucial for promoting and maintaining human health. These upgrades manifest in various aspects, including the integration of wearables, the implementation of data visualization, the support of artificial intelligence (AI) and machine learning (ML) in decision-making [9], and the incorporation of other state-of-the-art solutions. The review encompasses an assessment of the methodologies employed, the accuracy and reliability of predictions, and the limitations or challenges encountered in these models.

    Respectively, stress responses encompass intricate physiological mechanisms designed to aid the body in addressing perceived threats or challenges. These responses are governed by diverse pathways and systems, including the autonomic nervous system (ANS) with its sympathetic and parasympathetic branches [10],[11], as well as the endocrine system, notably the hypothalamic-pituitary-adrenal (HPA) axis [12]. The sympathetic nervous system (SNS), often termed the “fight or flight” system, activates in response to perceived threats, triggering the release of neurotransmitters like norepinephrine and epinephrine [13]. This activation elicits physiological changes such as heightened HR, lung airway dilation, increased blood flow to muscles, and enhanced alertness. Conversely, the parasympathetic nervous system (PNS) orchestrates the body's “rest and digest” response [11], counterbalancing sympathetic activation by inducing relaxation responses like lowered HR, airway constriction, and improved digestion. Meanwhile, the HPA axis assumes a pivotal role in stress response regulation. Upon stress perception, the hypothalamus secretes corticotropin-releasing hormone (CRH), stimulating the pituitary gland to release adrenocorticotropic hormone (ACTH) [13]. ACTH then prompts the adrenal glands to release cortisol, the primary stress hormone. Cortisol regulates energy metabolism, inflammation suppression, and immune function modulation. Prolonged HPA axis activation and elevated cortisol levels can lead to adverse health effects, including compromised immune function and increased susceptibility to chronic diseases.

    In terms of methodology and search strategies, the objective was to present a thorough examination of the subject matter within the confines of a concise review. The methodology encompassed targeted searches conducted across reputable academic databases, notably PubMed, Google Scholar, and pertinent conference proceedings. We employed a combination of specific keywords and phrases appropriate to the topic to identify relevant literature. The selection of references for Table 1 was based on the pertinence and significance of each publication to the themes under review, focusing on seminal works and recent contributions that significantly advanced understanding. Tables 3 and 5, detailing leading products/services and repositories, respectively, were compiled following a thorough review of publicly available resources. Factors such as impact and relevance to the overarching theme of the paper guided our selection process. This methodological rigor ensured a balanced and insightful exploration of the contemporary landscape of stress assessment and the utilization of wearable technology.

    This review is organized as follows: Section 2 presents related work for stress monitoring, Section 3 provides details on the physiological indicators of stress, details on the wearable devices in stress monitoring, commercial products and services that utilize stress-detection software, discussion on existing stress prediction models, and reference to open repositories and databases of stress-related data. Finally, Section 4 presents a summary and suggestions for future work.

    The identification of stress is a highly researched domain within the range of an individual's health, and numerous researchers have contributed to this field by presenting various approaches to measuring stress [14],[15]. Some have focused on “contactless” strategies, utilizing smartphone data (e.g., call/SMS logs, app usage, motion), voice processing, facial expression analysis, or keyboard typing behaviors. However, this review will focus on the use of wearable devices to measure physiological data for stress assessment. Notable works, like the one by Healey and Picard [16], demonstrated early success in detecting stress using physiological sensors. However, the environmental contexts in which stress detection is intended vary, ranging from constrained lab environments to unconstrained real-life scenarios. Some studies employ custom sensor suites, while others use commercially available sensors. The choice of sensors impacts factors like signal quality, reproducibility, and cost.

    The literature review also highlights diverse ML approaches for stress detection, including rule-based techniques, factor graph models, ensemble learning, and deep learning. Various studies utilize different physiological features and classifiers, leading to a wide range of reported accuracies. Despite the considerable efforts, there remains an open space for further exploration and improvement of prediction accuracy. The complexity of developing reliable stress-monitoring devices is underscored by the need for more consensus on the optimal approach and the imperative for thorough statistical analyses. Previous works in physiological stress sensing have employed various wearable sensors, such as electrocardiography (ECG) sensors [17][20], electrodermal activity (EDA) sensors [21][24], inductive respiration (RIP) sensors [20],[22],[24],[25], blood volume pulse (BVP) finger clip sensor [26][28], and electromyography (EMG) sensors [29][33], and wearable devices such as Fitbit Sense, Empatica E4, or Shimmer GSR3+ [34]. These sensors have been utilized in diverse conditions, including lab-induced stress, constrained real-life activities (e.g., driving, call centers, sleeping), and free-living conditions [23].

    In connection with the above, physiological measures like EDA, HR, and HRV are commonly used in studies related to well-being and affection [35]. Some studies propose smartwatch-based systems for discrete and cost-effective stress detection during daily activities. Kulkarni et al. [36] reviewed smart devices for health sensing from 2017 to 2022, covering diverse projects and methods for data collection and analysis, including exploring supplementary data for enhancing stress detection systems.

    The role of classification algorithms and ML techniques in stress detection is pivotal, as outlined in Table 3. Numerous studies have utilized a spectrum of algorithms, including but not limited to Naive Bayes, K-Nearest Neighbors Algorithm (KNN), Decision Trees (DT), Support Vector Machines (SVM), Random Forests (RF), Multi-layer Perceptron, AdaBoost, and Logistic Regression. Additionally, Support Vector Machine (SVM), Bayesian Networks (BN), Artificial Neural Network (ANN), Fuzzy Logic, and other computer-aided diagnostic (CAD) tools have been applied for classification purposes [37][43].

    In the existing literature, multiple studies have explored ensemble learning approaches in stress detection. For instance, Khullar et al. [44] introduced an ensemble model for stress detection utilizing physiological signals associated with anxiety. Issa [45] employed a two-step ensemble methodology for detecting stress in automobile drivers. Likewise, Di Martino & Delmastro [46] utilized an ensemble model for predicting physiological stress. Lee et al. [47] proposed an ensemble model that integrates deep learning models, including gated recurrent units, convolutional neural networks (CNN), and recurrent neural networks. Notably, the selection of sensors, data types, and classification algorithms varies among these studies, resulting in disparate classification accuracies.

    Exploring stress identification through wearable devices and physiological data has witnessed significant advancements, with researchers employing diverse methodologies and technologies. Incorporating diverse physiological features and classifiers has led to a spectrum of reported accuracies. However, despite considerable efforts, there remains an open space for further exploration and enhancement of prediction accuracy. The significance of classification algorithms in stress detection cannot be overstated, with studies employing a spectrum of algorithms (Table 3). Ensemble learning approaches have been particularly prevalent, as evidenced by studies introducing models designed for stress detection in various contexts [22],[48].

    The landscape of stress identification through wearable devices and physiological data is characterized by its complexity, diversity, and ongoing exploration. The integration of advanced technologies, ML techniques, and diverse physiological measures holds promise for the development of more accurate and reliable stress-monitoring devices in the future. However, the interdisciplinary nature of this field necessitates continued collaboration and research to address existing challenges and unlock the full potential of stress detection in diverse real-life scenarios [9],[34],[36],[40].

    A fundamental consideration in the assessment of stress involves the examination of its diverse components. Initially, stress specific to testing situations was perceived as a unified and one-dimensional concept by Mandler and Sarason [49]. Liebert and Morris [50] later introduced a distinction between “worry” (cognitive) and “emotionality” (affective) components, deviating from the initial dichotomous perspective on anxiety presented by Scherer [51]. Subsequent research embraced a multicomponent framework, acknowledging the interrelated nature of cognitive, affective, motivational, and physiological elements, departing from the earlier binary viewpoint on anxiety. This widely recognized classification highlights the theoretical differences among these components while emphasizing their interconnectedness. Although theoretically distinct, these emotional components, within the range of stress, demonstrate interrelated characteristics. These components encompass intrusive cognitive thoughts, affective expressions of nervousness, a motivational tendency to withdraw from the situation, and heightened physiological arousal, such as an elevated HR, increased perspiration, and physiological arousal [52][54].

    Physiological responses to stress span cardiovascular changes like heightened HR and blood pressure, respiratory alterations such as rapid breathing and muscular tension, cognitive enhancements in alertness and focus, metabolic shifts like increased glucose release for energy, and immunological adjustments involving the suppression of non-essential immune functions. Comprehending these physiological pathways and responses is vital for effectively assessing and managing stress. Monitoring parameters like HRV, cortisol levels, and immune function can offer valuable insights into an individual's stress levels and overall well-being.

    Stress responses involve a complex interplay of physiological pathways aimed at aiding the organism in dealing with perceived challenges. These mechanisms involve the ANS, which consists of the sympathetic and parasympathetic divisions, and the endocrine system, particularly the HPA axis [12],[55]. Upon encountering stressors, the SNS activates, leading to the release of neurotransmitters like epinephrine and norepinephrine. This activation induces various physiological changes, including increased HR, bronchodilation, enhanced blood flow to skeletal muscles, and heightened alertness. In contrast, the PNS initiates the body's “rest and digest” response, opposing sympathetic arousal by reducing HR and bronchoconstriction and promoting gastrointestinal activity. Concurrently, the HPA axis regulates stress responses by releasing CRH from the hypothalamus and stimulating the anterior pituitary to release ACTH, which, in turn, triggers the adrenal glands to secrete cortisol, the primary stress hormone. Cortisol modulates various physiological processes, including energy metabolism, inflammation regulation, and immune function [13]. Prolonged HPA axis activation and elevated cortisol levels can lead to adverse health consequences, such as compromised immune function and increased susceptibility to chronic diseases. Physiological responses to stress encompass changes in cardiovascular function, respiratory patterns, muscle tension, cognitive function, metabolic adjustments involving increased glucose release, and alterations in immune resource allocation, prioritizing immediate threats. Additionally, stress can influence metabolic biomarkers, antioxidants, glucose levels, hemoglobin, C-reactive protein (CRP), cytokines (including pro-inflammatory and anti-inflammatory cytokines), and tumor necrosis factor (TNF). Furthermore, research indicates that stress can be assessed through various biomarkers like hair cortisol, salivary cortisol, and urinary cortisol levels, providing insights into the physiological impacts of stress on the body [54][58].

    In the last two decades, there have been considerable advancements in stress assessment, coinciding with the development of physiological and biochemical sensing technologies. The sensors are a solid foundation for connected health solutions and proactive care in addressing various conditions related to or induced by stress [59],[60]. Stress is characterized as a disturbance in an individual's homeostatic balance, prompting the body to initiate what is known as the stress response [61]. Stress can be acute, an immediate reaction to a stressor, or chronic, a prolonged state resulting from constant stress stimuli [62]. Prolonged exposure to chronic stress may push the body to a point where it can no longer achieve a balanced state, rendering the individual unable to manage stressors effectively. The activation of the stress response induces various physiological changes driven by the stimulation of the SNS and the inhibition of the parasympathetic system. While the stress response can manifest differently, it typically involves the release of stress hormones that heighten the body's alertness. Consequently, there is an elevation in HR, blood supply to the muscles, respiratory rate, skin temperature (ST) (attributed to increased blood circulation), and cognitive activity, among other responses. Quantitative assessment or stress monitoring often involves analyzing stress-specific hormonal responses and other biomarkers affected by the stress response [61],[63].

    Stress evaluation can be conducted through subjective means, employing structured questionnaires and self-reporting forms, which aligns with standard clinical practice. Alternatively, objective assessment measures various bodily responses to stress [64]. Standard tools in clinical stress evaluation include self-reported questionnaires, exemplified by Cohen's Perceived Stress Scale (PSS) [4], and self-reported visual scales, such as the Visual Analogue Scale for Stress (VASS) [65]. Biomedical researchers utilize biochemical markers like cortisol and α-amylase to detect stress, often inducing a stress state in subjects through the Trier Social Stress Test (TSST) [66][70].

    Extensive literature exists on the monitoring of stress through the physiological or biochemical responses of the human body. However, a consensus remains elusive regarding the sensitivity and specificity of these physiological and biochemical indicators for identifying stress. The variability in sensitivity and specificity can be attributed to factors such as the responsiveness of the stress reaction, sensor sensitivity, the nature of stimulants, sample size in the study, experimental design, and other variables [41]. The literature review emphasizes the diverse range of wearable sensors that have been applied in various conditions, from controlled laboratory-induced stress to real-world activities and free-living scenarios. The selection of sensors underscores the necessity for adaptability to different stress-inducing situations. While there has been a notable surge in interest in physiological indicators over the past decade to complement traditional self-reports of emotions [71], applying these measures remains labor-intensive and costly, and interpreting findings within the context of existing educational research and theories remains challenging [10]. Until now, only a restricted number of studies have combined electrodermal measurements with self-reported stress assessments. Integrating electrodermal measures with self-report measures of anxiety is limited, with physiological measures commonly integrated into studies focused on well-being and affection. On the other side, smartwatch-based systems offer unobtrusive and cost-effective stress detection during daily activities, with devices like Empatica E4, Shimmer3 GSR+, or Movisense EdaMove providing a continuous assessment of physiological indicators, opening avenues for exploring the relationship among control, anxiety components, and daily performance.

    Biochemical stress indicators offer better detection and monitoring capabilities, but a drawback is that many of these indicators require invasive measurement methods. Some examples include cortisol, which typically requires the collection of saliva, blood, or urine samples for analysis; catecholamines such as epinephrine and norepinephrine, which are usually measured through blood samples; and certain inflammatory markers like interleukin-6 (IL-6), which also require blood samples for assessment [54],[58],[72]. In cases where noninvasive measurement is feasible, extracting the necessary hormones from collected samples takes time, making real-time stress monitoring devices impractical. There is potential in combining biochemical indicators, such as cortisol level measurement, with physiological indicators like HR, respiratory rate, and activity monitoring to create more resilient and precise stress-monitoring devices. Table 2 references biophysiological* and biochemical** stress parameters (sorted year-wise).

    Table 1.  Biophysiological* and biochemical** parameters of stress.
    Ref Year Signals Stressors
    [68] 2010 ECG, photoplethysmography (PPG), EDA, and ST [*BPH] Public speaking, mathematics, mental, social, and physical challenges
    [63] 2010 Salivary alpha-amylase, plasma catecholamines, blood pressure, and HR [**BC] College academic final exam
    [55] 2010 EEG, EDA PPG, and respiratory [*BPH] International Affective Picture System (IAPS)
    [94] 2011 ECG, respiratory, EDA, and EMG [*BPH] Perceived Stress Scale (PSS) questionnaire
    [95] 2012 Hair cortisol [**BC] Daily life stress (3 months)
    [96] 2012 ECG, EDA, and accelerometer (ACC) [*BPH] Stroop color test and mental arithmetic problems based on the Montreal Imaging Stress Task (MIST)
    [97] 2013 Sweat and saliva samples [**BC] Intense exercise
    [98] 2013 ECG, EMG, galvanic skin response (GSR), and ST (only concern on ECG and HRV) [*BPH] Stroop word–color test
    [99] 2014 ECG, respiratory, body temp, GSR [*BPH] Hajj pilgrimage (mandatory annual pilgrimage for all Muslims)
    [69] 2015 EDA and PPG [*BPH] Trier Scope Stress Test (TSST)
    [97] 2015 ECG and thoracic electrical bioimpedance (TEB) measurements [*BPH] Films game based on the addition
    [100] 2016 Steroid hormones in hair [**BC] Perceived Stress Questionnaire (PSQ)
    [41] 2016 EDA, PPG, and sociometric badge for recording [*BPH] STAI (State-Trait Anxiety Inventory) and TSST
    [34] 2017 ECG, EDA, and respiratory [*BPH] Real driving environment
    [101] 2017 EDA, ST, accelerometer (ACC), and PPG [*BPH] Randomly generated equations (solved verbally)
    [102] 2017 ECG and respiratory [*BPH] Montreal Imaging Stress Task (MIST)
    [103] 2017 PPG and inertial motion and driver behavior [*BPH] Euro truck driving simulator
    [56] 2018 Biochemical (salivary cortisol) and physiological domains (HRV measures) [**BC] Academic final examination, Psychological stress response inventory
    [104] 2018 ECG [*BPH] Daily life stress
    [105] 2018 PPG, ACC, and EDA [*BPH] City car driving simulator
    [106] 2018 EDA only ECG, EMG, and respiratory [*BPH] Driving on the highway in the city
    [107] 2018 Arginine, phenylalanine, acylcarnitines, sphingomyelin [**BC] Night shifts
    [70] 2019 ST, HR pulse wave EDA, ECG, PPG, copeptin, prolactin (blood), cortisol, and alpha-amylase (saliva) [**BC] Trier Social Stress Test (TSST)
    [108] 2019 PPG and endocrine (salivary) cortisol [**BC] Childhood Trauma Questionnaire (CTQ)
    [108] 2019 Oxy-hemoglobin (oxy-Hb) [**BC] Oxy-hemoglobin (oxy-Hb)
    [108] 2019 PPG, EDA, GSR, and ACC [*BPH] Summer camp (training, the contest, and free day)
    [109] 2019 EDA [*BPH] Driving on the highway in the city
    [110] 2020 GSR [*BPH] Predefined PYSIONET dataset and driving on the highway in the city
    [111] 2021 Plasma cortisol [**BC] Daily life stress
    [112] 2021 Copeptin, neurophysin II, vasopressin [**BC] Daily life stress
    [113] 2021 Cortisol, adrenaline, alpha-amylase, copeptin, and prolactin [**BC] Positive and Negative Affect Schedule (PANAS), State-Trait Anxiety Inventory (STAI), Self-Assessment Manikins questionnaire (SAM), Short Stress State Questionnaire (SSSQ)
    [114] 2021 BVP, ST (TEMP), EMG, photoplethysmogram (PPG), and EDA [*BPH] Montreal Imaging Stress Task (MIST)
    [111] 2022 Salivary alpha-amylase from saliva sample [**BC] Various stressors related to school engagement
    [86] 2022 Salivary cortisol was analyzed using the IDS-iSYS Multi-Discipline Automated System (Immunodiagnostic Systems Limited) [**BC] Triggered by stressors in individuals with regular, non-clinical functioning
    [111] 2022 Oxidative stress (urine analyzed using an immunoassay kit OxiSelect™ 8-iso-Prostaglandin F2a ELISA Kit from Cell Biolabs, Inc) [**BC] Various stressors related to school engagement and daily activities
    [57] 2023 Salivary cortisol [analyzed cortisol awakening response (CAR) and the diurnal baseline cortisol (DBC)] [**BC] Daily activities

     | Show Table
    DownLoad: CSV

    Implementing an automated stress-monitoring system benefits the self-management of mental and, consequently, physical well-being in a wide spectrum of individuals navigating the stress-laden environments of modern society. The intricacies that render the monitoring of stress a challenging and research-worthy endeavor include: i) subjectivity of stress: stress is highly subjective, with stimuli triggering the stress process varying between individuals; ii) defining ground truth: establishing the ground truth for stress detection proves challenging due to the subjective and continuous nature of the stress process, making it difficult to delineate the onset, duration, and intensity of a stress event; iii) indirect monitoring of stress: the stress response encompasses physiological, behavioral, and affective components. While certain aspects of the physiological response can be directly monitored using wearable devices (e.g., increased HR, sweating rate), there are no direct methods for monitoring the behavioral and affective components.

    Recent technological advancements have introduced wearable biosensors (e.g., ECG sensors, sweating-rate sensors [73], respiration-rate body sensors [74]) into daily life. The proliferation of wearables with bio-signal acquisition capabilities presents significant opportunities for advanced machine learning–enabled health monitoring and intervention applications. While literature demonstrates the feasibility of objectively detecting stress through biological signals, existing frameworks are often designed for controlled settings. Stress detection in everyday scenarios introduces inherent challenges such as real-time data collection and analysis, lower signal quality due to motion and noise artifacts (MNAs), and difficulties in collecting self-reports owing to limited user adherence [75]. Moreover, the personalization of stress monitoring in everyday settings poses additional challenges. User-specific features may emerge based on individual characteristics, behavioral patterns, physiology, context, and sensor setup/configuration, resulting in more variability than in controlled settings. These differences could degrade the performance of general classifiers in everyday scenarios.

    Implementing an automated stress-monitoring system holds great promise for enhancing the self-management of mental and physical well-being in the complex landscapes of contemporary society. The challenges associated with stress monitoring have been acknowledged, including the subjective nature of stress, difficulty defining ground truth, and the indirect nature of monitoring certain components. Nevertheless, recent technological strides in wearable biosensors, encompassing GPRS body control sensors, Bluetooth trackers, and smart clothes sensors, have opened avenues for leveraging advanced ML in health monitoring and interventions. Table 2 demonstrates the placement of different wearable biosensing devices used for stress monitoring.

    Table 2.  Summary of possible sites for wearable sensing technologies placement.
    Biosensing devices
    GPRS body control
    Smart glasses
    Smart watch
    Smart bracelets/wristbands
    Smart ring
    Bluetooth key tracker
    Smart belt
    Smart clothes (shirts, pants, shoes, socks)

     | Show Table
    DownLoad: CSV

    Considering the heightened acknowledgment of health issues associated with stress and the advancements in wearable biosensor technologies, a spectrum of commercial products and services has arisen, integrating stress-sensing software into their functions.

    Indicatively, they are divided into the following categories: i) smart wearables with embedded stress monitoring, ii) biofeedback devices, iii) stress-responsive mobile applications, iv) emotion recognition software, v) stress detection and monitoring platforms, etc.

    Smart wearable devices, ranging from smartwatches to fitness trackers, employ sensors such as ECG sensors, sweating-rate sensors, and respiration-rate body sensors to capture physiological indicators associated with stress. These wearables conduct real-time analysis of the gathered data using advanced ML algorithms, providing users with immediate insights into their stress levels. In parallel, biofeedback devices, such as HRV monitors and galvanic skin response sensors, contribute additional layers of physiological data, enabling a more comprehensive understanding of the user's stress profile.

    Mobile applications have been devised to complement stress-monitoring endeavors with wearable devices. These applications connect with wearables, collecting and consolidating data for a comprehensive stress analysis. Users can receive personalized stress reports, trend analyses, and actionable recommendations on managing stress. ML integration enables continuous accuracy improvement by adapting to individual stress response patterns over time.

    Accordingly, emotion recognition software, wearable devices, and mobile applications gain enhanced capabilities. Emotion-recognition algorithms can analyze facial expressions, voice tone, and speech patterns to discern emotional states. Integrating this software with wearables and apps augments the understanding of stress by incorporating emotional context. This synergy enables stress-detection platforms to offer more nuanced and personalized stress management guidance, including tailored coping strategies and interventions aligned with the user's emotional and physiological state. As technology evolves, the convergence of biofeedback and emotion recognition further refines the precision and effectiveness of stress management on an individualized level. Table 3 illustrates a sample of leading technological products and services employing stress-detection software.

    Table 3.  Leading technological products and services employing stress detection software.
    Type of device/Application Commercial name Parameters monitored
    Wearable device Empatica E4 EDA, temperature, HRV, and motion measurement
    Wearable device(s) VivoSense Wearable sensor technologies monitoring ECG, EMG, and EDA
    Wearable device Moodmetric Ring EDA and stress level measurement
    Wearable device Fitbit Stress tracking features, HRV, and stress management tools
    Wearable device Hexoskin Smart Shirt ECG, HRV, and breathing rate monitoring
    Wearable device Oura Ring HRV and sleep patterns monitoring
    Wearable device Garmin (Vivosmart) HRV, various physiological metrics
    Wearable device(s) Amazfit Band Series Stress level monitoring, HRV analysis
    Wearable device WHOOP Strap HRV, stress, and recovery optimization
    Wearable/biofeedback device(s) Biostrap HRV and sleep pattern monitoring, activity level tracking
    Biofeedback device/app Elite HRV HRV monitoring
    Biofeedback device Wild Divine's IomP EDA measurement, biofeedback games
    Biofeedback device(s)/app Shimmer3 GSR+ (Galvanic Skin Response) Changes in skin conductance measurement, ST
    Biofeedback device HeartMath Inner Balance HRV measurement, stress insights
    Biofeedback device EmWave by HeartMath EmWave devices for HRV biofeedback
    Biofeedback device Spire Health Tag Respiratory patterns tracking,
    Biofeedback device/app Muse brain activity (EEG) measurement, HRV
    Biofeedback Device/app/platform Welltory Biofeedback and HRV analyzation
    Mobile app Biospectal OptiBP Monitoring blood pressure via smartphone's camera
    Emotion recognition software/platform Affectiva Emotion recognition software, facial expression analysis, muscle tension
    Emotion recognition software Microsoft Azure Face API Facial expression analysis, emotion detection, muscle tension
    Emotion recognition software Beyond Verbal Vocal emotion analysis, speech patterns, emotion detection, muscle tension
    Emotion recognition software Noldus FaceReader Facial expression analysis, emotion recognition, HRV
    Emotion recognition software/app iMotions Facial expression analysis, a platform for biometric research
    Platform BioBeats Combination of wearable devices and ML algorithms for stress monitoring, insights based on physiological data
    Platform/App/Biofeedback Device Unyte iom2 Stress detection and monitoring, HRV, ST
    Platform/Wearable Devices Neumitra Physiological signals measurement, HRV, stress detection, and real-time feedback

     | Show Table
    DownLoad: CSV

    While the feasibility of objectively detecting stress through biological signals has been demonstrated, the transition from controlled settings to everyday scenarios introduces inherent complexities. Real-time data collection and analysis, mitigating motion and noise artifacts, and overcoming challenges in obtaining self-reports due to limited user adherence pose significant hurdles. Furthermore, the personalization of stress monitoring in daily life adds another layer of difficulty, with user-specific features stemming from individual characteristics, behavioral patterns, physiology, context, and sensor configurations, contributing to heightened variability.

    Despite the challenges mentioned above, the proliferation of wearable biosensing devices presents valuable opportunities for advancing stress-monitoring technologies. As illustrated in Table 2, the placement of various devices showcases the diversity in approaches. It underscores the need for continued research and innovation in tailoring stress-detection frameworks to meet the demands of real-world, everyday scenarios. As technology undergoes further advancements and corresponding products and services enter the commercial sphere, as indicated in Table 3, addressing these challenges will be crucial in realizing the full potential of automated stress monitoring for improving overall well-being in diverse populations.

    In the past, researchers have employed various devices and sensors to record physiological signals. While there is an overlap in the physiological signals measured across different studies, more needs to be explored into whether machine-learning models trained on data from one device can effectively generalize to the same physiological signal collected from a different device type. Research efforts have established a standard stress-detection framework involving signal cleaning, data normalization, segmentation, feature computation, classifier training, and performance assessment.

    As previous research has established a groundwork for stress detection, extensive research has concentrated on optimizing these steps by experimenting with different normalization techniques, cleaning methods, features, window sizes, and machine-learning models. Mishra et al. proposed a two-layered approach, considering stress in the preceding minute when making inferences about the current minute. This significantly enhances performance compared with standard single-model classification [76].

    While stress-detection models based on physiological sensing demonstrate efficacy in controlled lab environments, their performance degrades when deployed in free-living conditions—a consistent trend across studies. A primary reason for this discrepancy is that the wearable sensors utilized in these studies measure the body's physiological response to stress rather than stress itself. Free-living conditions can induce physiological responses that confound stress-detection models. Prior efforts have addressed this by accounting for physical activity in free-living conditions, improving model performance. However, focusing solely on physical activity may prove insufficient. Manual methods for stress measurement, such as examinations by psychologists and psychiatrists, are available but have disadvantages like cost and time. Technology offers an alternative, providing cost-effective and timely results. ML has been employed in stress detection, with studies utilizing models like random forest and support vector machines trained on physiological features. A hybrid ML model, combining two models, has shown promise in generating more significant stress detection results in accuracy and efficiency.

    Data from sensors undergo feature extraction, and ML or pattern recognition is employed to distinguish between stress and non-stress states (or baseline). ML algorithms fall into two primary categories. The first is supervised learning, where input and classification labels are provided to the model for prediction and classification. The second is unsupervised learning, where no labels are provided, and the model groups input data based on inherent patterns or similarities. Typically, sensor data is recorded on the device and transmitted to a computer or the cloud for processing and analysis. In certain scenarios, such as simulated driving, participants' wearable sensors are directly linked to a computer for real-time analysis during the experiment. As mentioned, various studies have utilized various algorithms, ML techniques, and other CAD tools (Table 4) for classification purposes [9],[30],[31],[35],[40].

    Table 4.  Summary of machine learning algorithms used in stress assessment.
    Algorithm Information
    Naive Bayes Naive Bayes is a probabilistic algorithm based on Bayes' theorem. It assumes independence between features, making it computationally efficient. It is widely used in classification tasks, particularly in natural language processing.
    Bayesian Networks (BN) Bayesian Networks represent probabilistic relationships among variables using a directed acyclic graph. They are employed for reasoning under uncertainty and are valuable in medical diagnosis, risk assessment, and decision-making systems.
    K-Nearest Neighbors Algorithm (KNN) KNN is a simple and effective algorithm used for classification and regression tasks. It classifies data points based on the majority class of their nearest neighbors.
    Decision Trees (DT) Decision Trees are tree-like models that make decisions based on features. They are widely used for classification and regression. Decision trees are interpretable but prone to overfitting, which techniques like pruning can address.
    Support Vector Machines (SVM) SVM is a powerful algorithm for classification and regression tasks. It identifies a hyperplane that best separates data into classes. SVM is effective in high-dimensional spaces and is commonly used in image classification and bioinformatics.
    Random Forests (RF) Random Forests are an ensemble-learning method based on multiple decision trees. They enhance accuracy and mitigate overfitting by aggregating the predictions of individual trees. Random Forests are widely used for diverse machine-learning tasks.
    Multi-Layer Perceptron Multi-Layer Perceptron is an artificial neural network with multiple layers, including input, hidden, and output layers. It excels in learning complex patterns and is widely used in deep learning applications.
    AdaBoost AdaBoost is an ensemble-learning algorithm that combines weak learners to create a strong classifier. It assigns more weight to misclassified data points, emphasizing their importance in subsequent iterations.
    Logistic Regression Logistic Regression is a statistical method used for binary classification. Despite its name, it is a linear model widely used when the relationship between the dependent variable and predictors is logistic.
    Convolutional Neural Network (CNN) CNN is a deep learning algorithm for processing structured grid data like images. It utilizes convolutional layers to learn hierarchical features automatically. CNNs are widely employed in image recognition tasks.
    Artificial Neural Network (ANN) ANN is a computational model inspired by the human brain. Comprising interconnected nodes (neurons), it can learn complex relationships in data. ANNs are used in various fields, including finance, healthcare, and image processing.
    Fuzzy Logic Fuzzy Logic deals with uncertainty and imprecision in data by allowing partial membership to a set. It is employed in control systems, decision-making, and AI applications where exact reasoning is challenging.
    Computer-Aided Diagnostic (CAD) Tools CAD tools utilize various algorithms, including ML and statistical methods, to assist in medical diagnoses. They analyze medical data such as images, helping healthcare professionals make more informed decisions.

     | Show Table
    DownLoad: CSV

    The developing discipline of stress detection via wearable technology has emphasized the significance of accessible and diverse datasets for progressing respective research. Acknowledging the important role of data in formulating and validating stress-detection models, various initiatives have been introduced to establish open repositories dedicated to stress-related physiological signals. These repositories support researchers by facilitating the collaborative exploration of stress-related datasets, contributing to the reproducibility and comparability of studies, and promoting a more robust understanding of stress detection across various contexts and populations.

    A noteworthy initiative in this domain involves the aggregation of datasets encompassing physiological signals derived from a spectrum of wearable devices. These datasets systematically incorporate a range of stress-inducing scenarios, including controlled lab environments and free-living conditions. Including diverse stressors and real-world contexts aims to address the observed performance degradation of stress-detection models when transitioning from controlled settings to everyday life.

    These open repositories feature raw physiological data and provide comprehensive annotations, including ground-truth labels for stress and non-stress states. The availability of labeled data is paramount for the training and evaluation of machine-learning models. Furthermore, some repositories incorporate metadata detailing the type of wearable sensors used, cleaning and normalization techniques applied, and other pertinent information that enhances the interpretability and generalizability of the datasets.

    Table 5 includes references to various open repositories that provide stress-related data for formulating and validating stress-detection models.

    Table 5.  Open repositories of stress-related data.
    Ref Repository/Database Description
    [115] WESAD (wearable stress and affect detection) (2018) A publicly available dataset for wearable stress and affect detection research.
    [116] AMIGOS (dataset for affect, personality, and mood research on individuals and groups) (2021) A dataset designed for emotion and stress recognition research, capturing physiological signals in response to multimedia stimuli.
    [117] MAHNOB-HCI (multimodal database for affective computing and human-computer interaction) A multimodal dataset containing physiological signals for research in affective computing and human-computer interaction.
    [118] DREAMER: a database for emotion recognition through EEG and ECG signals from wireless low-cost off-the-shelf devices A dataset designed for emotion recognition research, measuring EEG and ECG signals in response to audio and visual stimuli in film.
    [119] SWELL: the swell knowledge work dataset for stress and user modeling research A dataset containing data to study stress and user modeling collected from participants while performing work activities.
    [120][124] SEED (stress recognition using EEG and EDA databases) Focuses on stress recognition using electroencephalogram (EEG) and EDA signals
    [125] HEROES: a video-based human emotion recognition database A database for motion identification (whole-body movements) and recognition.
    [72] AffectNet database A database for facial expression, valence, and arousal estimation related to stress and emotion research.
    [126] DEAP (database for emotion analysis using physiological signals) A database containing physiological and electroencephalogram (EEG) signals for emotion analysis research.
    [3] BioVid heat pain database It investigates physiological responses to heat pain stimuli for pain and stress research.
    [127] PHYSIOLAB dataset A dataset containing physiological signals for studying stress and emotion in realistic scenarios.
    [128] AMASS (affect, motivation, and ambiance stress study) A dataset for studying the relationship between stress and emotions in realistic environments.
    [129] CREMA-D (crowd-sourced emotional multimodal actors dataset) A dataset for emotion and affective computing research, including physiological signals and facial expressions.
    [130] Multi-modal stress dataset (MMSD) for real-time, continuous stress detection MMSD is a multimodal acute stress dataset that includes physiological signals (ECG, PPG, EDA, and EMG) for stress detection.
    [131] The University of Waterloo Stress Dataset (UWS) UWS dataset contains physiological data, including HRV, EDA, and ECG, for stress identification in daily life conditions.
    [132] OpenFace Project The OpenFace project provides tools for facial behavior analysis, which can be used in stress and emotion research.

     | Show Table
    DownLoad: CSV

    In summary, the accessibility of open repositories significantly facilitates the advancement of research by fostering collaboration and sharing datasets. Particularly significant is the available platform IEEE DataPort [77] (hosting various datasets, including those related to physiological signals and stress) and free repositories, such as the Open Science Framework (OSF) [78], a comprehensive platform supporting the entire research lifecycle, where researchers commonly disseminate their datasets. Zenodo [79], developed under the European OpenAIRE program, stands as a general-purpose open-access repository accepting datasets from diverse scientific fields. Figshare [80] offers researchers a platform to publicly share various research outputs, including datasets, while Data.gov [81] provides a comprehensive resource spanning diverse domains, offering access to numerous datasets that may benefit researchers exploring stress-related phenomena. Additionally, the NIH Data Sharing Repositories [82] curated by the National Institutes of Health serve as a valuable reference, encompassing various biomedical and health-related research areas. These open repositories contribute to the open science ethos and enhance accessibility and collaboration within the broader research community.

    In summary, this scientific review explores the intricate domain of stress assessment, particularly on incorporating wearable technology for the objective evaluation and real-time prediction of stress levels. The pervasive nature of stress in contemporary society accentuates the imperative for proactive interventions, and the emergence of wearable devices represents the necessity for addressing this imperative. The investigation into physiological stress indicators underscores the importance of metrics that can be seamlessly captured through wearable devices. Particularly noteworthy is the continuous monitoring of parameters such as HR and breathing patterns, providing real-time data and valuable insights into individuals' health. The correlations between these physiological markers and stress levels are examined, focusing on comprehending the consistency of these associations across diverse populations.

    With their capability for real-time data acquisition, wearable devices assume a pivotal role in monitoring stress. The review acknowledges their effectiveness in providing individuals with immediate feedback on health indicators, facilitating the timely detection of patterns indicative of stress or anxiety. Nonetheless, the review underscores the challenges associated with these devices, encompassing data accuracy, reliability, privacy, and security considerations. Furthermore, emphasis is placed on the imperative to formulate efficacious interventions based on the collected data, thereby underscoring the practical ramifications associated with integrating wearables into stress management strategies. The findings of Burtscher et al. emphasize the potential for wearables to extend beyond general stress management, particularly in addressing non-motor symptoms in Parkinson's disease [83]. This fact highlights a promising avenue for future research and application, showcasing the broader impact of wearable systems on managing various stress-related symptoms across different medical conditions.

    The integration of wearable technology within clinical environments presents promising avenues for personalized medicine. These devices can facilitate early diagnosis, continuous remote monitoring, and customized interventions across various medical conditions [85][87],[133]. Ongoing advancements in wearable technology, characterized by enhancements in sensor capabilities and algorithmic sophistication, can significantly augment healthcare professionals' capacity to evaluate and address stress-related symptoms among patients with diverse clinical profiles [86],[87].

    As wearable technology emerges as a versatile tool for clinical practice, the deployment of sophisticated biosensors within these devices stands poised to enable the timely detection of cardiovascular events through the meticulous monitoring of physiological parameters such as heart rate variability and blood pressure [87],[88]. Likewise, integrating respiratory monitoring functionalities within wearables offers promising avenues for managing chronic respiratory ailments such as asthma and chronic obstructive pulmonary disease (COPD) [86],[89],[90]. Furthermore, the convergence of wearable glucose monitors with automated insulin delivery systems represents a notable stride in diabetes management, facilitating continuous monitoring of blood glucose levels and responsive insulin administration [91]. Furthermore, incorporating physiological sensors and machine learning algorithms into wearable devices implies significant strides in identifying and managing mental health disorders [5],[39],[92]. Additionally, wearable motion sensors hold considerable promise in rehabilitation and physical therapy, offering precise monitoring of movement patterns and real-time feedback to optimize therapeutic interventions [93]. These examples emphasize the transformative potential of wearable technology in healthcare, underscoring its capacity to afford personalized monitoring and intervention across various medical conditions.

    The investigation into established stress prediction models reveals the continuous progression of biotechnology, coupled with its integration with state-of-the-art solutions, including AI and ML. The evaluation encompasses the methodologies utilized, the precision and dependability of predictions, and the encountered limitations or challenges. This comprehensive analysis contributes to a differentiated comprehension of the current landscape, establishing a foundation for future advancements in stress prediction models. Exploring stress prediction models reveals advancements in biotechnology, integrating AI and ML. The review assesses methodologies, precision, and limitations, contributing to a nuanced understanding of the current landscape and laying the foundation for future advancements. However, fundamental difficulties persist, including lacking a universally accepted definition of stress, physiological responses to stressors, and confounding factors like physical activity, that challenge stress-detection models. Reproducibility issues arise from custom hardware usage without testing applicability across devices, studies, populations, or demographics. Moreover, stress monitoring is challenging due to subjectivity, making it difficult to define the ground truth. Stress events' start, duration, and intensity are elusive, and the threefold stress response (physiological, behavioral, and affective) complicates direct monitoring. The difficulty in monitoring behavioral and affective responses highlights the need for innovative approaches.

    The impact of stress on individuals and society is significant, and wearable devices hold great potential for stress management. However, it is crucial to approach wearable technology integration carefully, considering its capabilities and limitations. This review highlights this field's achievements while emphasizing the need for further investigation. Collaborative efforts among researchers, healthcare professionals, and technology developers are necessary to fully harness wearables' transformative potential in stress management. Despite technical challenges, wearables have significant potential to mitigate the adverse effects of stress and contribute to improved individual and public health outcomes.

    The authors declare they have not used Artificial Intelligence (AI) tools in the creation of this article.



    [1] Bürk K (2017) Friedreich Ataxia: current status and future prospects. Cerebellum Ataxias.
    [2] Leonard H, Cobb S, Downs J (2016) Clinical and biological progress over 50 years in Rett syndrome. Nat Rev Neurol 13: 37–51.
    [3] Auburger G, Klinkenberg M, Drost J, et al. (2012) Primary Skin Fibroblasts as a Model of Parkinson's Disease. Mol Neurobiol 46: 20–27. doi: 10.1007/s12035-012-8245-1
    [4] Petters RM, Sommer JR (2000) Transgenic animals as models for human disease. Transgenic Res 9: 347–351. doi: 10.1023/A:1008926303533
    [5] Hargus G, Ehrlich M, Hallmann AL, et al. (2014) Human stem cell models of neurodegeneration: A novel approach to study mechanisms of disease development. Acta Neuropathol 127: 151–173. doi: 10.1007/s00401-013-1222-6
    [6] Ilic D, Ogilvie C (2017) Concise Review: Human Embryonic Stem Cells-What Have We Done? What Are We Doing? Where Are We Going? Stem Cells 35: 17–25.
    [7] Randolph LN, Jiang Y, Lian X (2017) Stem Cell Engineering and Differentiation for Disease Modeling and Cell-based Therapies. AIMS Cell Tissue Eng 1: 140–157. doi: 10.3934/celltissue.2017.2.140
    [8] Takahashi K, Yamanaka S (2006) Induction of Pluripotent Stem Cells from Mouse Embryonic and Adult Fibroblast Cultures by Defined Factors. Cell 126: 663–676. doi: 10.1016/j.cell.2006.07.024
    [9] Takahashi K, Tanabe K, Ohnuki M, et al. (2007) Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors. Cell 131: 861–872. doi: 10.1016/j.cell.2007.11.019
    [10] Poon A, Zhang Y, Chandrasekaran A, et al. (2017) Modeling neurodegenerative diseases with patient-derived induced pluripotent cells: Possibilities and challenges. N Biotechnol 39: 190–198. doi: 10.1016/j.nbt.2017.05.009
    [11] Tabar V, Studer L (2014) Pluripotent stem cells in regenerative medicine: Challenges and recent progress. Na Rev Genet 15: 82–92. doi: 10.1038/nrg3563
    [12] Mertens J, Marchetto MC, Bardy C, et al. (2016) Evaluating cell reprogramming, differentiation and conversion technologies in neuroscience. Nat Rev Neurosci 17: 424–437. doi: 10.1038/nrn.2016.46
    [13] Lancaster M, Renner M, Martin C, et al. (2013) Cerebral organoids model human brain development and microcephaly. Nature 501: 373–379. doi: 10.1038/nature12517
    [14] Pasca AM, Sloan SA, Clarke LE, et al. (2015) Functional cortical neurons and astrocytes from human pluripotent stem cells in 3D culture. Nat Methods 12: 671–678. doi: 10.1038/nmeth.3415
    [15] Soldner F, Laganière J, Cheng AW, et al. (2011) Generation of Isogenic Pluripotent Stem Cells Differing Exclusively at Two Early Onset Parkinson Point Mutations. Cell 146: 318–331. doi: 10.1016/j.cell.2011.06.019
    [16] Bassett AR (2017) Editing the genome of hiPSC with CRISPR/Cas9: disease models. Mamm Genome 28: 348–364. doi: 10.1007/s00335-017-9684-9
    [17] Thomson JA, Itskovitz-Eldor J, Shapiro SS, et al. (1998) Embryonic stem cell lines derived from human blastocysts. Science 282: 1145–1147.
    [18] Wilmut I, Schnieke AE, McWhir J, et al. (1997) Viable offspring derived from fetal and adult mammalian cells. Nature 385: 810–813. doi: 10.1038/385810a0
    [19] Cowan CA, Atienza J, Melton DA, et al. (2005) Nuclear reprogramming of somatic cells after fusion with human embryonic stem cells. Science 309: 1369–1373. doi: 10.1126/science.1116447
    [20] Yu J, Vodyanik MA, Smuga-Otto K, et al. (2007) Induced Pluripotent Stem Cell Lines Derived from Human Somatic Cells. Science 318: 1917–1920. doi: 10.1126/science.1151526
    [21] Okita K, Matsumura Y, Sato Y, et al. (2011) A more efficient method to generate integration-free human iPS cells. Nat Methods 8: 409. doi: 10.1038/nmeth.1591
    [22] Daley GQ (2014) Dissecting reprogramming, differentiation and conversion with network biology. Leuk Suppl 3: S3–S4. doi: 10.1038/leusup.2014.2
    [23] Zhou W, Freed CR (2009) Adenoviral Gene Delivery Can Reprogram Human Fibroblasts to Induced Pluripotent Stem Cells. Stem Cells 27: 2667–2674. doi: 10.1002/stem.201
    [24] Zhou Y, Zeng F (2013) Integration-free Methods for Generating Induced Pluripotent Stem Cells. Genom Proteom Bioinform 11: 284–287. doi: 10.1016/j.gpb.2013.09.008
    [25] Nakanishi M, Otsu M (2012) Development of Sendai Virus Vectors and their Potential Applications in Gene Therapy and Regenerative Medicine. Curr Gene Ther 12: 410–416. doi: 10.2174/156652312802762518
    [26] Kim D, Kim CH, Moon JI, et al. (2009) Generation of Human Induced Pluripotent Stem Cells by Direct Delivery of Reprogramming Proteins. Cell Stem Cell 4: 472–476. doi: 10.1016/j.stem.2009.05.005
    [27] Okita K, Yamanaka S (2011) Induced pluripotent stem cells: opportunities and challenges. Philos Trans R Soc B Biol Sci 366: 2198–2207. doi: 10.1098/rstb.2011.0016
    [28] Paridaen JT, Huttner WB (2014) Neurogenesis during development of the vertebrate central nervous system. EMBO Rep 15: 351–364. doi: 10.1002/embr.201438447
    [29] Chandrasekaran A, Avci HX, Ochalek A, et al. (2017) Comparison of 2D and 3D neural induction methods for the generation of neural progenitor cells from human induced pluripotent stem cells. Stem Cell Res 25: 139–151. doi: 10.1016/j.scr.2017.10.010
    [30] Chuang JH (2015) Neural differentiation from embryonic stem cells in vitro : An overview of the signaling pathways. World J Stem Cells 7: 437. doi: 10.4252/wjsc.v7.i2.437
    [31] Chambers SM, Fasano CA, Papapetrou EP, et al. (2009) Highly efficient neural conversion of human ES and iPS cells by dual inhibition of SMAD signaling. Nat Biotechnol 27: 275–280. doi: 10.1038/nbt.1529
    [32] Qi Y, Zhang XJ, Renier N, et al. (2017) Combined small-molecule inhibition accelerates the derivation of functional cortical neurons from human pluripotent stem cells. Nat Biotechnol 35: 154–163. doi: 10.1038/nbt.3777
    [33] Kim DS, Jung SJ, Lee JS, et al. (2017) Rapid generation of OPC-like cells from human pluripotent stem cells for treating spinal cord injury. Exp Mole Med 49: e361. doi: 10.1038/emm.2017.106
    [34] Wang S, Bates J, Li X, et al. (2013) Human iPSC-derived oligodendrocyte progenitor cells can myelinate and rescue a mouse model of congenital hypomyelination. Cell Stem Cell 12: 252–264. doi: 10.1016/j.stem.2012.12.002
    [35] Xu XH, Zhong Z (2013) Disease modeling and drug screening for neurological diseases using human induced pluripotent stem cells. Acta Pharmacol Sin 34: 755–764. doi: 10.1038/aps.2013.63
    [36] Lojewski X, Staropoli JF, Biswas-legrand S, et al. (2014) Human iPSC models of neuronal ceroid lipofuscinosis capture distinct effects of TPP1 and CLN3 mutations on the endocytic pathway. Hum Mol Genet 23: 2005–2022. doi: 10.1093/hmg/ddt596
    [37] Espuny-Camacho I, Michelsen KA, Linaro D, et al. (2018) Human Pluripotent Stem-Cell-Derived Cortical Neurons Integrate Functionally into the Lesioned Adult Murine Visual Cortex in an Area-Specific Way. Cell Rep 23: 2732–2743. doi: 10.1016/j.celrep.2018.04.094
    [38] Dwyer ND, Chen B, Chou SJ, et al. (2016) Neural Stem Cells to Cerebral Cortex: Emerging Mechanisms Regulating Progenitor Behavior and Productivity. J Neurosci 36: 11394–11401. doi: 10.1523/JNEUROSCI.2359-16.2016
    [39] Rigamonti A, Repetti GG, Sun C, et al. (2016) Large-Scale Production of Mature Neurons from Human Pluripotent Stem Cells in a Three-Dimensional Suspension Culture System. Stem cell Rep 6: 993–1008. doi: 10.1016/j.stemcr.2016.05.010
    [40] Gunhanlar N, Shpak G, van der Kroeg M, et al. (2018) A simplified protocol for differentiation of electrophysiologically mature neuronal networks from human induced pluripotent stem cells. Mol Psychiatry 23: 1336–1344. doi: 10.1038/mp.2017.56
    [41] Alcamo EA, Chirivella L, Dautzenberg M, et al. (2008) Satb2 regulates callosal projection neuron identity in the developing cerebral cortex. Neuron 57: 364–377. doi: 10.1016/j.neuron.2007.12.012
    [42] Britanova O, de Juan Romero C, Cheung A, et al. (2008) Satb2 is a postmitotic determinant for upper-layer neuron specification in the neocortex. Neuron 57: 378–392. doi: 10.1016/j.neuron.2007.12.028
    [43] Shi Y, Kirwan P, Livesey FJ (2012) Directed differentiation of human pluripotent stem cells to cerebral cortex neurons and neural networks. Nat Protoc 7: 1836–1846. doi: 10.1038/nprot.2012.116
    [44] Chen B, Wang SS, Hattox AM, et al. (2008) The Fezf2-Ctip2 genetic pathway regulates the fate choice of subcortical projection neurons in the developing cerebral cortex. Proc Nat Acad Sci 105: 11382–11387. doi: 10.1073/pnas.0804918105
    [45] Espuny-Camacho I, Michelsen KA, Gall D, et al. (2013) Pyramidal neurons derived from human pluripotent stem cells integrate efficiently into mouse brain circuits in vivo. Neuron 77: 440–456. doi: 10.1016/j.neuron.2012.12.011
    [46] Elkabetz Y, Panagiotakos G, Al Shamy G, et al. (2008) Human ES cell-derived neural rosettes reveal a functionally distinct early neural stem cell stage. Genes Dev 22: 152–165. doi: 10.1101/gad.1616208
    [47] Paşca SP, Portmann T, Voineagu I, et al. (2011) Using iPSC-derived neurons to uncover cellular phenotypes associated with Timothy syndrome. Nat Med 17: 1657–1662. doi: 10.1038/nm.2576
    [48] Davis-Dusenbery BN, Williams LA, Klim JR, et al. (2014) How to make spinal motor neurons. Development 141: 491–501. doi: 10.1242/dev.097410
    [49] Santiago C, Bashaw GJ (2014) Transcription factors and effectors that regulate neuronal morphology. Development 141: 4667–4680. doi: 10.1242/dev.110817
    [50] Stifani N (2014) Motor neurons and the generation of spinal motor neuron diversity. Front Cell Neurosci 8: 293.
    [51] Du ZW, Chen H, Liu H, et al. (2015) Generation and expansion of highly pure motor neuron progenitors from human pluripotent stem cells. Nat Commun 6: 6626. doi: 10.1038/ncomms7626
    [52] Hester ME, Murtha MJ, Song S, et al. (2011) Rapid and efficient generation of functional motor neurons from human pluripotent stem cells using gene delivered transcription factor codes. Mol Ther 19: 1905–1912. doi: 10.1038/mt.2011.135
    [53] Di Giorgio FP, Boulting GL, Bobrowicz S, et al. (2008) Human Embryonic Stem Cell-Derived Motor Neurons Are Sensitive to the Toxic Effect of Glial Cells Carrying an ALS-Causing Mutation. Cell Stem Cell 3: 637–648. doi: 10.1016/j.stem.2008.09.017
    [54] Amoroso MW, Croft GF, Williams DJ, et al. (2013) Accelerated high-yield generation of limb-innervating motor neurons from human stem cells. J Neurosci 33: 574–586. doi: 10.1523/JNEUROSCI.0906-12.2013
    [55] Karumbayaram S, Novitch BG, Patterson M, et al. (2009) Directed differentiation of human-induced pluripotent stem cells generates active motor neurons. Stem Cells 27: 806–811. doi: 10.1002/stem.31
    [56] Toma JS, Shettar BC, Chipman PH, et al. (2015) Motoneurons derived from induced pluripotent stem cells develop mature phenotypes typical of endogenous spinal motoneurons. J Neurosci 35: 1291–1306. doi: 10.1523/JNEUROSCI.2126-14.2015
    [57] Pepper JP, Wang TV, Hennes V, et al. (2017) Human induced pluripotent stem cell–derived motor neuron transplant for neuromuscular atrophy in a mouse model of sciatic nerve injury. JAMA Facial Plast Surg 19: 197. doi: 10.1001/jamafacial.2016.1544
    [58] Chandrasekaran A, Avci HX, Leist M, et al. (2016) Astrocyte differentiation of human pluripotent stem cells: New tools for neurological disorder research. Front Cell Neurosci 10: 215.
    [59] Santos R, Vadodaria KC, Jaeger BN, et al. (2017) Differentiation of inflammation-responsive astrocytes from glial progenitors generated from human induced pluripotent stem cells. Stem Cell Rep 8: 1757–1769. doi: 10.1016/j.stemcr.2017.05.011
    [60] TCW J, Wang M, Pimenova AA, et al. (2017) An Efficient Platform for Astrocyte Differentiation from Human Induced Pluripotent Stem Cells. Stem Cell Rep 9: 600–614. doi: 10.1016/j.stemcr.2017.06.018
    [61] Liu H, Zhang SC (2011) Specification of neuronal and glial subtypes from human pluripotent stem cells. Cell Mol Life Sci 68: 3995–4008. doi: 10.1007/s00018-011-0770-y
    [62] Krencik R, Weick JP, Liu Y, et al. (2011) Specification of transplantable astroglial subtypes from human pluripotent stem cells. Nat Biotechnol 29: 528–534. doi: 10.1038/nbt.1877
    [63] Jiang P, Chen C, Liu XB, et al. (2016) Human iPSC-Derived Immature Astroglia Promote Oligodendrogenesis by Increasing TIMP-1 Secretion. Cell Rep 15: 1303–1315. doi: 10.1016/j.celrep.2016.04.011
    [64] Nistor GI, Totoiu MO, Haque N, et al. (2005) Human embryonic stem cells differentiate into oligodendrocytes in high purity and myelinate after spinal cord transplantation. Glia 49: 385–396. doi: 10.1002/glia.20127
    [65] Hu BY, Du ZW, Zhang SC (2009) Differentiation of human oligodendrocytes from pluripotent stem cells. Nat Protoc 4: 1614–1622. doi: 10.1038/nprot.2009.186
    [66] Goldman SA, Kuypers NJ (2015) How to make an oligodendrocyte. Development 142: 3983–3995. doi: 10.1242/dev.126409
    [67] Doerr J, Böckenhoff A, Ewald B, et al. (2015) Arylsulfatase A Overexpressing Human iPSC-derived Neural Cells Reduce CNS Sulfatide Storage in a Mouse Model of Metachromatic Leukodystrophy. Mol Ther 23: 1519–1531. doi: 10.1038/mt.2015.106
    [68] Pouya A, Satarian L, Kiani S, et al. (2011) Human induced pluripotent stem cells differentiation into oligodendrocyte progenitors and transplantation in a rat model of optic chiasm demyelination. PLoS One 6: e27925. doi: 10.1371/journal.pone.0027925
    [69] Lippmann ES, Azarin SM, Kay JE, et al. (2012) Derivation of blood-brain barrier endothelial cells from human pluripotent stem cells. Na Biotechnol 30: 783–791. doi: 10.1038/nbt.2247
    [70] Appelt-Menzel A, Cubukova A, Günther K, et al. (2017) Establishment of a human blood-brain barrier co-culture model mimicking the neurovascular unit using induced pluri- and multipotent stem cells. Stem Cell Rep 8: 894–906. doi: 10.1016/j.stemcr.2017.02.021
    [71] Busskamp V, Lewis NE, Guye P, et al. (2014) Rapid neurogenesis through transcriptional activation in human stem cells. Mol Syst Biol 10: 760–760. doi: 10.15252/msb.20145508
    [72] Zhang Y, Pak CH, Han Y, et al. (2013) Rapid single-step induction of functional neurons from human pluripotent stem cells. Neuron 78: 785–798. doi: 10.1016/j.neuron.2013.05.029
    [73] Wang C, Ward ME, Chen R, et al. (2017) Scalable Production of iPSC-Derived Human Neurons to Identify Tau-Lowering Compounds by High-Content Screening. Stem Cell Rep 9: 1221–1233. doi: 10.1016/j.stemcr.2017.08.019
    [74] Fernandopulle MS, Prestil R, Grunseich C, et al. (2018) Transcription Factor–Mediated Differentiation of Human iPSCs into Neurons. Curr Protoc Cell Biol 79: e51. doi: 10.1002/cpcb.51
    [75] Li X, Tao Y, Bradley R, et al. (2018) Fast Generation of Functional Subtype Astrocytes from Human Pluripotent Stem Cells. Stem Cell Rep 11: 998–1008. doi: 10.1016/j.stemcr.2018.08.019
    [76] Ehrlich M, Mozafari S, Glatza M, et al. (2017) Rapid and efficient generation of oligodendrocytes from human induced pluripotent stem cells using transcription factors. Proc Natl Acade Sci U S A 114: E2243–E2252. doi: 10.1073/pnas.1614412114
    [77] García-León JA, Kumar M, Boon R, et al. (2018) SOX10 Single Transcription Factor-Based Fast and Efficient Generation of Oligodendrocytes from Human Pluripotent Stem Cells. Stem Cell Rep 10: 655–672. doi: 10.1016/j.stemcr.2017.12.014
    [78] Ardhanareeswaran K, Mariani J, Coppola G, et al. (2017) Human induced pluripotent stem cells for modelling neurodevelopmental disorders. Nat Rev Neurol 13: 265–278. doi: 10.1038/nrneurol.2017.45
    [79] Shovlin S, Tropea D (2018) Transcriptome level analysis in Rett syndrome using human samples from different tissues. Orphanet J Rare Dis 13: 113. doi: 10.1186/s13023-018-0857-8
    [80] Chahrour M, Zoghbi HY (2007) The Story of Rett Syndrome: From Clinic to Neurobiology. Neuron 56: 422–437. doi: 10.1016/j.neuron.2007.10.001
    [81] Huidobro C, Fernandez AF, Fraga MF (2013) The role of genetics in the establishment and maintenance of the epigenome. Cell Mol Life Sci 70: 1543–1573. doi: 10.1007/s00018-013-1296-2
    [82] Kishi N, Macklis JD (2004) MECP2 is progressively expressed in post-migratory neurons and is involved in neuronal maturation rather than cell fate decisions. Mol Cell Neurosci 27: 306–321. doi: 10.1016/j.mcn.2004.07.006
    [83] Damen D, Heumann R (2013) MeCP2 phosphorylation in the brain: From transcription to behavior. Biol Chem 394: 1595–1605.
    [84] Hendrich B, Bird A (1998) Identification and Characterization of a Family of Mammalian Methyl-CpG Binding Proteins. Mol Cell Biol 18: 6538–6547. doi: 10.1128/MCB.18.11.6538
    [85] Gold WA, Krishnarajy R, Ellaway C, et al. (2018) Rett Syndrome: A Genetic Update and Clinical Review Focusing on Comorbidities. ACS Chem Neurosci 9: 167–176. doi: 10.1021/acschemneuro.7b00346
    [86] Ausió J (2018) Role of MeCP2 in neurological disorders: current status and future perspectives. Epigenomics 10: 5–8. doi: 10.2217/epi-2017-0128
    [87] Linda K, Fiuza C, Nadif Kasri N (2018) The promise of induced pluripotent stem cells for neurodevelopmental disorders. Prog Neuropsychopharmacol Biol Psychiatry 84: 382–391. doi: 10.1016/j.pnpbp.2017.11.009
    [88] Marchetto MC, Carromeu C, Acab A, et al. (2010) A model for neural development and treatment of Rett syndrome using human induced pluripotent stem cells. Cell 143: 527–539. doi: 10.1016/j.cell.2010.10.016
    [89] Kim KY, Hysolli E, Park IH (2011) Neuronal maturation defect in induced pluripotent stem cells from patients with Rett syndrome. Proc Natl Acad Sci U S A 108: 14169–14174. doi: 10.1073/pnas.1018979108
    [90] Farra N, Zhang WB, Pasceri P, et al. (2012) Rett syndrome induced pluripotent stem cell-derived neurons reveal novel neurophysiological alterations. Mol Psychiatry 17: 1261–1271. doi: 10.1038/mp.2011.180
    [91] Cheung AY, Horvath LM, Grafodatskaya D, et al. (2011) Isolation of MECP2-null Rett Syndrome patient hiPS cells and isogenic controls through X-chromosome inactivation. Hum Mol Genet 20: 2103–2115. doi: 10.1093/hmg/ddr093
    [92] Djuric U, Cheung AYL, Zhang W, et al. (2015) MECP2e1 isoform mutation affects the form and function of neurons derived from Rett syndrome patient iPS cells. Neurobiol Dis 76: 37–45. doi: 10.1016/j.nbd.2015.01.001
    [93] Lioy DT, Garg SK, Monaghan CE, et al. (2011) A role for glia in the progression of Rett's syndrome. Nature 475: 497–500. doi: 10.1038/nature10214
    [94] Williams EC, Zhong X, Mohamed A, et al. (2014) Mutant astrocytes differentiated from Rett syndrome patients-specific iPSCs have adverse effects on wildtype neurons. Hum Mol Genet 23: 2968–2980. doi: 10.1093/hmg/ddu008
    [95] Pearn JH (1978) Incidence, prevalence, and gene frequency studies of chronic childhood spinal muscular atrophy. J Med Genet 15: 409–413. doi: 10.1136/jmg.15.6.409
    [96] Ebert AD, Svendsen CN (2010) Stem cell model of spinal muscular atrophy. Arch Neurol 67: 665–669.
    [97] Sareen D, Ebert AD, Heins BM, et al. (2012) Inhibition of apoptosis blocks human motor neuron cell death in a stem cell model of spinal muscular atrophy. PLoS One 7: e39113. doi: 10.1371/journal.pone.0039113
    [98] Liu Q, Fischer U, Wang F, et al. (1997) The spinal muscular atrophy disease gene product, SMN, and its associated protein SIP1 are in a complex with spliceosomal snRNP proteins. Cell 90: 1013–1021. doi: 10.1016/S0092-8674(00)80367-0
    [99] Fischer U, Liu Q, Dreyfuss G (1997) The SMN-SIP1 complex has an essential role in spliceosomal snRNP biogenesis. Cell 90: 1023–1029. doi: 10.1016/S0092-8674(00)80368-2
    [100] Rossoll W, Jablonka S, Andreassi C, et al. (2003) Smn, the spinal muscular atrophy-determining gene product, modulates axon growth and localization of β-actin mRNA in growth cones of motoneurons. J Cell Biol 163: 801–812. doi: 10.1083/jcb.200304128
    [101] Farrar MA, Kiernan MC (2015) The Genetics of Spinal Muscular Atrophy: Progress and Challenges. Neurotherapeutics 12: 290–302. doi: 10.1007/s13311-014-0314-x
    [102] Corti S, Nizzardo M, Simone C, et al. (2012) Genetic correction of human induced pluripotent stem cells from patients with spinal muscular atrophy. Sci Transl Med 4: 165ra162.
    [103] Yoshida M, Kitaoka S, Egawa N, et al. (2015) Modeling the early phenotype at the neuromuscular junction of spinal muscular atrophy using patient-derived iPSCs. Stem Cell Rep 4: 561–568. doi: 10.1016/j.stemcr.2015.02.010
    [104] Mcgivern JV, Patitucci TN, Nord JA, et al. (2013) Spinal muscular atrophy astrocytes exhibit abnormal calcium regulation and reduced growth factor production. Glia 61: 1418–1428. doi: 10.1002/glia.22522
    [105] Zhou C, Feng Z, Ko CP (2016) Defects in Motoneuron-Astrocyte Interactions in Spinal Muscular Atrophy. J Neurosci 36: 2543–2553. doi: 10.1523/JNEUROSCI.3534-15.2016
    [106] Almad AA, Maragakis NJ (2012) Glia: An emerging target for neurological disease therapy. Stem Cell Res Ther 3: 37. doi: 10.1186/scrt128
    [107] Cloake NC, Yan J, Aminian A, et al. (2018) PLP1 mutations in patients with multiple sclerosis: Identification of a new mutation and potential pathogenicity of the mutations. J Clin Med 7: 100. doi: 10.3390/jcm7050100
    [108] Hobson GM, Kamholz J (1993) PLP1-Related Disorders. GeneReviews®.
    [109] Garbern JY (2007) Pelizaeus-Merzbacher disease: Genetic and cellular pathogenesis. Cell Mol Life Sci 64: 50–65. doi: 10.1007/s00018-006-6182-8
    [110] Numasawa-Kuroiwa Y, Okada Y, Shibata S, et al. (2014) Involvement of ER stress in dysmyelination of pelizaeus-merzbacher disease with PLP1 missense mutations shown by iPSC-derived oligodendrocytes. Stem Cell Rep 2: 648–661. doi: 10.1016/j.stemcr.2014.03.007
    [111] Takahashi T, Suzuki T (2012) Role of sulfatide in normal and pathological cells and tissues. J Lipid Res 53: 1437–1450. doi: 10.1194/jlr.R026682
    [112] Patil SA, Maegawa GHB (2013) Developing therapeutic approaches for metachromatic leukodystrophy. Drug Des Devel Ther 7: 729–745.
    [113] Ramakrishnan H, Hedayati KK, Lüllmann-Rauch R, et al. (2007) Increasing sulfatide synthesis in myelin-forming cells of arylsulfatase A-deficient mice causes demyelination and neurological symptoms reminiscent of human metachromatic leukodystrophy. J Neurosci 27: 9482–9490. doi: 10.1523/JNEUROSCI.2287-07.2007
    [114] Deconinck N, Messaaoui A, Ziereisen F, et al. (2008) Metachromatic leukodystrophy without arylsulfatase A deficiency: A new case of saposin-B deficiency. Eur J Paediatr Neurol 12: 46–50. doi: 10.1016/j.ejpn.2007.05.004
    [115] Frati G, Luciani M, Meneghini V, et al. (2018) Human iPSC-based models highlight defective glial and neuronal differentiation from neural progenitor cells in metachromatic leukodystrophy. Cell Death Dis 9: 698. doi: 10.1038/s41419-018-0737-0
    [116] Meneghini V, Frati G, Sala D, et al. (2017) Generation of human induced pluripotent stem cell-derived bona fide neural stem cells for ex vivo gene therapy of metachromatic leukodystrophy. Stem Cells Transl Med 6: 352–368. doi: 10.5966/sctm.2015-0414
    [117] Messing A, LaPash Daniels CM, Hagemann TL (2010) Strategies for Treatment in Alexander Disease. Neurotherapeutics 7: 507–515. doi: 10.1016/j.nurt.2010.05.013
    [118] Prust M, Wang J, Morizono H, et al. (2011) GFAP mutations, age at onset, and clinical subtypes in Alexander disease. Neurology 77: 1287–1294. doi: 10.1212/WNL.0b013e3182309f72
    [119] Jones JR, Kong L, Hanna MG, et al. (2018) Mutations in GFAP Disrupt the Distribution and Function of Organelles in Human Astrocytes. Cell Rep 25: 947–958.e4. doi: 10.1016/j.celrep.2018.09.083
    [120] Kondo T, Funayama M, Miyake M, et al. (2016) Modeling Alexander disease with patient iPSCs reveals cellular and molecular pathology of astrocytes. Acta Neuropathol Commun 4: 69. doi: 10.1186/s40478-016-0337-0
    [121] Li L, Tian E, Chen X, et al. (2018) GFAP Mutations in Astrocytes Impair Oligodendrocyte Progenitor Proliferation and Myelination in an hiPSC Model of Alexander Disease. Cell Stem Cell 23: 239–251.e6. doi: 10.1016/j.stem.2018.07.009
    [122] Anheim M, Lagier-Tourenne C, Stevanin G, et al. (2009) SPG11 spastic paraplegia: A new cause of juvenile parkinsonism. J Neurol 256: 104–108. doi: 10.1007/s00415-009-0083-3
    [123] Örlén H, Melberg A, Raininko R, et al. (2009) SPG11 mutations cause Kjellin syndrome, a hereditary spastic paraplegia with thin corpus callosum and central retinal degeneration. Am J Med Genet B Neuropsychiatric Genet 150: 984–992.
    [124] Renvoisé B, Chang J, Singh R, et al. (2014) Lysosomal abnormalities in hereditary spastic paraplegia types SPG15 and SPG11. Ann Clin Trans Neurol 1: 379–389. doi: 10.1002/acn3.64
    [125] Murmu RP, Martin E, Rastetter A, et al. (2011) Cellular distribution and subcellular localization of spatacsin and spastizin, two proteins involved in hereditary spastic paraplegia. Mol Cell Neurosci 47: 191–202. doi: 10.1016/j.mcn.2011.04.004
    [126] Hirst J, Borner GH, Edgar J, et al. (2013) Interaction between AP-5 and the hereditary spastic paraplegia proteins SPG11 and SPG15. Mole Biol Cell 24: 2558–2569. doi: 10.1091/mbc.e13-03-0170
    [127] Pérez-Brangulí F, Mishra HK, Prots I, et al. (2014) Dysfunction of spatacsin leads to axonal pathology in SPG11-linked hereditary spastic paraplegia. Hum Mol Genet 23: 4859–4874. doi: 10.1093/hmg/ddu200
    [128] Mishra HK, Prots I, Havlicek S, et al. (2016) GSK3ß-dependent dysregulation of neurodevelopment in SPG11-patient induced pluripotent stem cell model. Ann Neurol 79: 826–840. doi: 10.1002/ana.24633
    [129] Varga RE, Khundadze M, Damme M, et al. (2015) In vivo evidence for lysosome depletion and impaired autophagic clearance in hereditary spastic paraplegia type SPG11. PLoS Genet 11: e1005454. doi: 10.1371/journal.pgen.1005454
    [130] LaMarca EA, Powell SK, Akbarian S, et al. (2018) Modeling neuropsychiatric and neurodegenerative diseases with induced pluripotent stem cells. Front Pediatr 6: 82. doi: 10.3389/fped.2018.00082
    [131] Tian F, Hao J, Hu L, et al. (2018) Modeling neurodegenerative diseases by human pluripotent stem cell-induced brain organoid. Transl Surg 3: 42. doi: 10.4103/ts.ts_4_18
    [132] Wang H (2018) Modeling neurological diseases with human brain organoids. Front Synaptic Neurosci 10: 15. doi: 10.3389/fnsyn.2018.00015
    [133] Gabriel E, Wason A, Ramani A, et al. (2016) CPAP promotes timely cilium disassembly to maintain neural progenitor pool. EMBO J 35: 803–819. doi: 10.15252/embj.201593679
    [134] Li Y, Muffat J, Omer A, et al. (2016) Induction of expansion and folding in human cerebral organoids. Cell Stem Cell 20: 385–396.e3.
    [135] Mariani J, Coppola G, Zhang P, et al. (2015) FOXG1-Dependent Dysregulation of GABA/Glutamate Neuron Differentiation in Autism Spectrum Disorders. Cell 162: 375–390. doi: 10.1016/j.cell.2015.06.034
    [136] Kim YG, Cha J, Chandrasegaran S (1996) Hybrid restriction enzymes: zinc finger fusions to Fok I cleavage domain. Proc Natl Acad Sci U S A 93: 1156–1160. doi: 10.1073/pnas.93.3.1156
    [137] Porteus MH, Baltimore D (2003) Chimeric nucleases stimulate gene targeting in human cells. Science 300: 763. doi: 10.1126/science.1078395
    [138] Wang Y, Zhang WY, Hu S, et al. (2012) Genome Editing of Human Embryonic Stem Cells and Induced Pluripotent Stem Cells With Zinc Finger Nucleases for Cellular Imaging. Circ Res 111: 1494–1503. doi: 10.1161/CIRCRESAHA.112.274969
    [139] Ramalingam S, London V, Kandavelou K, et al. (2013) Generation and genetic engineering of human induced pluripotent stem cells using designed zinc finger nucleases. Stem Cells Dev 22: 595–610. doi: 10.1089/scd.2012.0245
    [140] Wood AJ, Lo TW, Zeitler B, et al. (2011) Targeted Genome Editing Across Species Using ZFNs and TALENs. Science 333: 307–307. doi: 10.1126/science.1207773
    [141] Sanjana NE, Cong L, Zhou Y, et al. (2012) A transcription activator-like effector toolbox for genome engineering. Nat Protoc 7: 171–192. doi: 10.1038/nprot.2011.431
    [142] Cong L, Ran FA, Cox D, et al. (2013) Multiplex genome engineering using CRISPR/Cas systems. Science 339: 819–823. doi: 10.1126/science.1231143
    [143] Mali P, Yang L, Esvelt KM, et al. (2013) RNA-guided human genome engineering via Cas9. Science 339: 823–826. doi: 10.1126/science.1232033
    [144] Suzuki T, Asami M, Perry ACF (2015) Asymmetric parental genome engineering by Cas9 during mouse meiotic exit. Sci Rep 4: 7621. doi: 10.1038/srep07621
    [145] Smith C, Gore A, Yan W, et al. (2014) Whole-genome sequencing analysis reveals high specificity of CRISPR/Cas9 and TALEN-based genome editing in human iPSCs. Cell Stem Cell 15: 12–13. doi: 10.1016/j.stem.2014.06.011
    [146] Smith C, Abalde-Atristain L, He C, et al. (2015) Efficient and allele-specific genome editing of disease loci in human iPSCs. Mol Ther 23: 570–577. doi: 10.1038/mt.2014.226
    [147] He X, Li YX, Feng B (2018) New Turns for High Efficiency Knock-In of Large DNA in Human Pluripotent Stem Cells. Stem Cells Int 2018: 1–7.
    [148] Fu Y, Reyon D, Keith Joung J (2014) Targeted genome editing in human cells using CRISPR/Cas nucleases and truncated guide RNAs. Methods Enzymol 546: 21–45.
    [149] Tsai SQ, Wyvekens N, Khayter C, et al. (2014) Dimeric CRISPR RNA-guided FokI nucleases for highly specific genome editing. Nat Biotechnol 32: 569–576. doi: 10.1038/nbt.2908
    [150] Raitano S, Ordovàs L, De Muynck L, et al. (2015) Restoration of progranulin expression rescues cortical neuron generation in an induced pluripotent stem cell model of frontotemporal dementia. Stem Cell Rep 4: 16–24. doi: 10.1016/j.stemcr.2014.12.001
    [151] Ebert AD, Yu J, Rose FF, et al. (2009) Induced pluripotent stem cells from a spinal muscular atrophy patient. Nature 457: 277–280. doi: 10.1038/nature07677
    [152] Simone C, Ramirez A, Bucchia M, et al. (2016) Is spinal muscular atrophy a disease of the motor neurons only: Pathogenesis and therapeutic implications? Cell Mol Life Sci 73: 1003–1020. doi: 10.1007/s00018-015-2106-9
    [153] Ramirez A, Crisafulli SG, Rizzuti M, et al. (2018) Investigation of New Morpholino Oligomers to Increase Survival Motor Neuron Protein Levels in Spinal Muscular Atrophy. Int J Mol Sci 19: E167. doi: 10.3390/ijms19010167
    [154] Klose RJ, Sarraf SA, Schmiedeberg L, et al. (2005) DNA Binding Selectivity of MeCP2 Due to a Requirement for A/T Sequences Adjacent to Methyl-CpG. Mol Cell 19: 667–678. doi: 10.1016/j.molcel.2005.07.021
    [155] Mellios N, Woodson J, Garcia RI, et al. (2014) β2-Adrenergic receptor agonist ameliorates phenotypes and corrects microRNA-mediated IGF1 deficits in a mouse model of Rett syndrome. Proc Natl Acad Sci U S A 111: 9947–9952. doi: 10.1073/pnas.1309426111
    [156] Chang Q, Khare G, Dani V, et al. (2006) The disease progression of Mecp2 mutant mice is affected by the level of BDNF expression. Neuron 49: 341–348. doi: 10.1016/j.neuron.2005.12.027
    [157] Wang H, Chan SA, Ogier M, et al. (2006) Dysregulation of brain-derived neurotrophic factor expression and neurosecretory function in Mecp2 null mice. J Neurosci 26: 10911–10915. doi: 10.1523/JNEUROSCI.1810-06.2006
    [158] Li W, Pozzo-Miller L (2014) BDNF deregulation in Rett syndrome. Neuropharmacology 76: 737–746. doi: 10.1016/j.neuropharm.2013.03.024
    [159] Williams EC, Zhong X, Mohamed A, et al. (2014) Mutant astrocytes differentiated from Rett syndrome patients-specific iPSCs have adverse effects on wild-type neurons. Hum Mol Genet 23: 2968–2980. doi: 10.1093/hmg/ddu008
    [160] Zhu JM, Zhao YY, Chen SD, et al. (2011) Functional recovery after transplantation of neural stem cells modified by brain-derived neurotrophic factor in rats with cerebral ischaemia. J Int Med Res 39: 488–498. doi: 10.1177/147323001103900216
    [161] Behrstock S, Ebert AD, Klein S, et al. (2008) Lesion-induced increase in survival and migration of human neural progenitor cells releasing GDNF. Cell Transplant 17: 753–762. doi: 10.3727/096368908786516819
    [162] Hjelm BE, Grunseich C, Gowing G, et al. (2016) Mifepristone-inducible transgene expression in neural progenitor cells in vitro and in vivo. Gene Ther 23: 424–437. doi: 10.1038/gt.2016.13
  • This article has been cited by:

    1. Eman Abdelfattah, Shreehar Joshi, Shreekar Tiwari, Machine and Deep Learning Models for Stress Detection Using Multimodal Physiological Data, 2025, 13, 2169-3536, 4597, 10.1109/ACCESS.2024.3525459
    2. Meenal Kamlakar, Lalit Patil, Dipti Patil, 2024, Non Invasive Stress Detection in Pregnant Women: A Smart IOT based System, 979-8-3503-5434-8, 1, 10.1109/ICBDS61829.2024.10837466
    3. Manasi Khadanga, Nihar Ranjan Kar, Nityananda Sahoo, Bichitrananda Tripathy, Recent advancements in digital and traditional treatment strategies for major depressive disorder using medicinal herbs, 2024, 7, 25893777, 365, 10.1016/j.dcmed.2025.01.002
    4. Bishal Thapa, Micaela Rivas, Henry Griffith, Heena Rathore, 2025, StressLLM: Large Language Models for Stress Prediction via Wearable Sensor Data, 979-8-3315-2116-5, 1, 10.1109/ICCE63647.2025.10929774
    5. Jun-Zhi Xiang, Qin-Yong Wang, Zhi-Bin Fang, James A. Esquivel, Zhi-Xian Su, A multi-modal deep learning approach for stress detection using physiological signals: integrating time and frequency domain features, 2025, 16, 1664-042X, 10.3389/fphys.2025.1584299
    6. Huanya Zhu, Qiang Chen, Shijuan Wei, Xuebing Wu, Qianqian Ju, Jinmeng Liu, Yiqun Gan, A systematic review and Bayesian network meta-analysis on the efficacy and potential of mobile interventions for stress management, 2025, 2397-3374, 10.1038/s41562-025-02162-0
    7. Thabitha. S, Suresh. A, G. Rajeswari, 2025, Accurate Human Stress Detection from Sleeping Habits Using a Hybrid Ensemble of Machine Learning Models, 979-8-3315-3755-5, 1, 10.1109/ICDSAAI65575.2025.11011643
    8. Marketa Ciharova, Khadicha Amarti, Ward van Breda, Martin J. Gevonden, Sina Ghassemi, Annet Kleiboer, Christiaan H. Vinkers, Milou S. C. Sep, Sophia Trofimova, Alexander C. Cooper, Xianhua Peng, Mieke Schulte, Eirini Karyotaki, Pim Cuijpers, Heleen Riper, Machine-learning detection of stress severity expressed on a continuous scale using acoustic, verbal, visual, and physiological data: lessons learned, 2025, 16, 1664-0640, 10.3389/fpsyt.2025.1548287
  • Reader Comments
  • © 2019 the Author(s), licensee AIMS Press. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0)
通讯作者: 陈斌, bchen63@163.com
  • 1. 

    沈阳化工大学材料科学与工程学院 沈阳 110142

  1. 本站搜索
  2. 百度学术搜索
  3. 万方数据库搜索
  4. CNKI搜索

Metrics

Article views(6030) PDF downloads(1674) Cited by(1)

/

DownLoad:  Full-Size Img  PowerPoint
Return
Return

Catalog